Predictive value of the Leuven HRD test compared with Myriad myChoice PLUS on 468 ovarian cancer samples from the PAOLA-1/ENGOT-ov25 trial (LBA 6)-Reference-Cited by-同舟云学术

Predictive value of the Leuven HRD test compared with Myriad myChoice PLUS on 468 ovarian cancer samples from the PAOLA-1/ENGOT-ov25 trial (LBA 6)

Published:2022-08 Issue: Volume:166 Page:S51-S52
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Loverix Liselore,Vergote Ignace,Busschaert Pieter,Vanderstichele Adriaan,Boeckx Bram,Venken Tom,Harter Philipp,Brems Hilde,Nieuwenhuysen Els Van,Pignata Sandro,Baert Thaïs,Gonzalez-Martin Antonio,Han Sileny,Marth Christian,Neven Patrick,Colombo Nicoletta,Berteloot Patrick,Mäenpää Johanna,Olbrecht Siel,Laga Tina,Sablon Erwin,Ray-Coquard Isabelle,Pujade-Lauraine Eric,Lambrechts Diether,Gorp Toon Van

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly (adenosine diphosphate‐ribose) polymerase inhibitors in the treatment of triple‐negative breast cancer with homologous repair deficiency;Medicinal Research Reviews;2024-06-24

2. Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations;JAMA Network Open;2024-04-09

3. High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency–Associated Genomic Instability in Ovarian Cancer;JCO Precision Oncology;2024-03

4. Evaluation of Homologous Recombination Deficiency in Ovarian Cancer;Current Treatment Options in Oncology;2024-02

5. Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer;2023-12-08